about
On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factorsAlterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseasesPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorRac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine TherapyHematopoietic cell transplantation for Crohn's disease; is it time?PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice.State of the art: IBD therapy and clinical trials in IBD.Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease.Moxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitisImmunopathogenesis of IBD: insufficient suppressor function in the gut?Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitisHaematopoietic SCT in autoimmune diseases in children: rationale and new perspectives.Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population.Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention.Cell death at the intestinal epithelial front line.Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine.E. coli-produced BMP-2 as a chemopreventive strategy for colon cancer: a proof-of-concept study.Infliximab in ulcerative colitis.Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab).Reciprocal regulation of the survival and apoptosis of Th17 and Th1 cells in the colon.Serum m 30 levels reflects ulcerative colitis activity.Role of DOR-β-arrestin1-Bcl2 signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis.Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease.
P2860
Q24812542-2DE3104A-92C0-4E54-AAAC-D67A827E83ACQ27016000-00F629CF-3F3E-4D3C-A6E7-871F98648C5BQ27022976-F5D76C38-F173-412A-89D0-AA8D6AEC8ADBQ28067937-7F136540-5D52-4DB5-964A-AF2F0BE09D26Q34017756-A41F8740-BD31-4903-9C97-9CC8B6C212BDQ34876574-F40E941F-6E72-4253-ADB3-BEAC3E1DBB2EQ36299319-C31DE0E4-DAE5-409F-963B-A02A87937D95Q36418973-95C013AB-C164-451B-BA0E-F7C5446C1CE0Q36461032-D21FF0B6-CDBB-42EE-9303-EDE6EC7F578BQ36626285-1E2FA8B0-F2D1-4C89-A446-740DCE747471Q36755033-099334FD-0B88-4D30-980B-D70161D7B8E0Q37188496-9409FE68-D66C-4163-A473-A8EE10863213Q37243620-DF585D6F-80A2-47FF-910E-5D671BBD0710Q37828318-1588C67D-760F-4C0E-A5B7-FF070E193409Q38616012-AB5D4207-E7B5-40B3-97EB-19BADCDB6FCBQ38831233-54E264BD-91F8-4B50-A978-D39C6BDE5F1AQ40795458-18E67DE3-4971-45B6-9501-C005C0BD6692Q41860347-3D3C7268-4DDA-4DDA-8883-CDC90955E192Q42113781-0AB0FDB2-1D79-4044-8AFF-8CC5D9FAFBA8Q44043343-17CF2250-0048-41C0-9DF4-766896DB1E32Q47779699-644AF1B1-CEB4-4244-AD81-C1713ED1354AQ51311354-D315408F-D268-434B-8485-2A3BD646EE03Q54364656-799183AB-7D46-432C-906A-3AB065BC84A5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
T cell apoptosis and inflammatory bowel disease.
@ast
T cell apoptosis and inflammatory bowel disease.
@en
type
label
T cell apoptosis and inflammatory bowel disease.
@ast
T cell apoptosis and inflammatory bowel disease.
@en
prefLabel
T cell apoptosis and inflammatory bowel disease.
@ast
T cell apoptosis and inflammatory bowel disease.
@en
P2860
P356
P1433
P1476
T cell apoptosis and inflammatory bowel disease.
@en
P2093
Peppelenbosch MP
van Deventer SJ
P2860
P304
P356
10.1136/GUT.2004.040824
P407
P577
2004-11-01T00:00:00Z